December 22, 2008

Truvada, Viread and Emtriva Co-Pay Assistance Program Now Available

Gilead Sciences has launched a Truvada co-payment assistance program to help eligible people living with HIV reduce their out-of-pocket medication expenses. The program kicks in for insurance co-payments above $50 and covers up to $200 a month for Truvada (tenofovir plus emtricitabine), as well as Viread (tenofovir) and Emtriva (emtricitabine) if they are used separately.

HIV-positive people are eligible for the new Gilead program if they have out-of-pocket costs associated with insurance co-payments for their medications and their prescriptions are not covered by Medicaid, Medicare, a state AIDS Drug Assistance Program (ADAP) or other government-funded assistance program.

Because of its licensing agreement with Bristol-Myers Squibb, Gilead is unable to extend its co-payment assistance program to prescriptions for Atripla (efavirenz, tenofovir and emtricitabine). Additionally, Massachusetts residents are not eligible for the program.

Patients can enroll by obtaining a co-payment assistance card from their physicians or health care providers. If a health care provider does not have a card available, patients can call a toll-free number (888.358.0398) to enroll immediately and receive a card in the mail.

Search: Truvada, Viread, Emtriva, Atripla, co-payment, insurance, ADAP, Medicaid, Medicare, assistance

Scroll down to comment on this story.

Previous Comments:

egg, , 2009-01-09 09:03:51
This is not such a generous program [as well as these folks] because of the minimum 50.01 co pay requirement. You must have BAD insurance. People with good insurance need not apply. only after you are made to feel bad for having good insurance.

suresh Babu, Hyderabad, 2008-12-30 01:34:33
Please I want HIV cure medication Truvada medication available in Hyderabad city please tell me Address or any places tell me Address and phone numbers. Thanq sir.

David Warren, San Francisco, 2008-12-24 13:33:54
"The program kicks in for insurance co-payments above $50 and covers up to $200 a month for Truvada (tenofovir plus emtricitabine), as well as Viread (tenofovir) and Emtriva (emtricitabine) if they are used separately." Does this mean only co-payments associated with these specific meds or can the cumulative total of co-payments for all HIV meds in a patients regimen qualify for $50 and $200 thresholds?